Lanean...

Polyvalent pneumococcal polysaccharide vaccines

A 14-valent pneumococcal vaccine has recently been licensed for general use after extensive testing in human subjects. Antibody production was satisfactory in 92% of individuals and a highly significant (76-92%) reduction was found in the rates for pneumococcal pneumonias caused by the capsular type...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hilleman, M. R., McLean, A. A., Vella, P. P., Weibel, R. E., Woodhour, A. F.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1978
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395578/
https://ncbi.nlm.nih.gov/pubmed/28857
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!